Publications

Publications published since 2000 or in press from OUS - Department of Urology

119 publications found

Publications in press

  1. Fosså A, Røsok BI, Kazaryan AM, Holte HJ, Brennhovd B, Westerheim O, Marangos IP, Edwin B
    Laparoscopic versus open surgery in stage I-III adrenocortical carcinoma - a retrospective comparison of 32 patients
    Acta Oncol (in press)
    PubMed 23398621
  2. Grytli HH, Fagerland MW, Fosså SD, Taskén KA
    Reply to Chris R. Cardwell, Samy Suissa and Liam J. Murray's Letter to the Editor re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association Between Use of ?-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007
    Eur Urol (in press)
    PubMed 23602404
  3. Grytli HH, Fagerland MW, Fosså SD, Taskén KA
    Association Between Use of ?-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
    Eur Urol (in press)
    PubMed 23351721
  4. Holm HV, Fosså SD, Hedlund H, Dahl AA
    Study of generic quality of life in patients operated on for post-prostatectomy incontinence
    Int J Urol (in press)
    PubMed 23418855
  5. Liu Y, Wu X, Li X, Kvalheim G, Axcrona U, Axcrona K, Suo Z
    Blocking mtDNA Replication Upregulates the Expression of Stemness-related Genes in Prostate Cancer Cell Lines
    Ultrastruct Pathol (in press)
    PubMed 23634795
  6. Stensvold A, Dahl AA, Brennhovd B, Småstuen MC, Fosså SD, Lilleby W, Steinsvik A, Axcrona K, Smeland S
    Bother problems in prostate cancer patients after curative treatment
    Urol Oncol (in press)
    PubMed 22341412

Publications 2013

  1. Berge V, Berg RE, Hoff JR, Wessel N, Diep LM, Karlsen SJ, Eri LM (2013)
    A prospective study of transition from laparoscopic to robot-assisted radical prostatectomy: quality of life outcomes after 36-month follow-up
    Urology, 81 (4), 781-6
    PubMed 23465150
  2. Eide T, Ramberg H, Glackin C, Tindall D, Taskén KA (2013)
    TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells
    Cancer Cell Int, 13 (1), 4
    PubMed 23368843
  3. Grytli HH, Fagerland MW, Fosså SD, Taskén KA, Håheim LL (2013)
    Use of ?-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
    Prostate, 73 (3), 250-60
    PubMed 22821802
  4. Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, Mansson W, Mills RD, Penson DF, Skinner EC, Stein R, Studer UE, Thueroff JW, Turner WH, Volkmer BG, Xu A (2013)
    ICUD-EAU International Consultation on Bladder Cancer 2012: urinary diversion
    Eur Urol, 63 (1), 67-80
    PubMed 22995974
  5. Hole KH, Axcrona K, Lie AK, Vlatkovic L, Geier OM, Brennhovd B, Knutstad K, Olsen DR, Seierstad T (2013)
    Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
    Eur Radiol, 23 (4), 1158-66
    PubMed 23114883
  6. Lindberg J, Mills IG, Klevebring D, Liu W, Neiman M, Xu J, Wikström P, Wiklund P, Wiklund F, Egevad L, Grönberg H (2013)
    The mitochondrial and autosomal mutation landscapes of prostate cancer
    Eur Urol, 63 (4), 702-8
    PubMed 23265383
  7. Sharma NL, Massie CE, Ramos-Montoya A, Zecchini V, Scott HE, Lamb AD, MacArthur S, Stark R, Warren AY, Mills IG, Neal DE (2013)
    The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man
    Cancer Cell, 23 (1), 35-47
    PubMed 23260764
  8. Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2013)
    Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
    Scand J Urol, 47 (2), 92-100
    PubMed 22860630

Publications 2012

  1. Andersen AV, Granlund P, Schultz A, Talseth T, Hedlund H, Frich L (2012)
    Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis
    Scand J Urol Nephrol, 46 (4), 284-9
    PubMed 22452583
  2. Axcrona K, Aaltomaa S, da Silva CM, Ozen H, Damber JE, Tankó LB, Colli E, Klarskov P (2012)
    Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide
    BJU Int, 110 (11), 1721-8
    PubMed 22500884
  3. Berge V, Berg RE, Hoff JR, Wessel N, Svindland A, Karlsen SJ, Eri LM (2012)
    Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer
    Scand J Urol Nephrol, 46 (1), 8-13
    PubMed 21843041
  4. Dimmen M, Vlatkovic L, Hole KH, Nesland JM, Brennhovd B, Axcrona K (2012)
    Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies
    BJU Int, 110 (2 Pt 2), E69-75
    PubMed 22093091
  5. Frøen H, Brennhovd B, Abeler VM, Madsbu UE, Lehne G (2012)
    [Young man with severe back pain]
    Tidsskr Nor Laegeforen, 132 (14), 1626-9
    PubMed 22875130
  6. Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD, Leung R, Schinzel AC, Mills I, Ross-Adams H, Neal DE, Kido M, Yamamoto T, Petrozziello G, Stack EC, Lis R, Kantoff PW, Loda M, Sartor O, Egawa S, Tewari AK, Hahn WC, Freedman ML (2012)
    Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis
    Proc Natl Acad Sci U S A, 109 (28), 11252-7
    PubMed 22730461
  7. Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B, Zhang H, Cerniglia G, Bi M, Li Y, Gao Y, Liu H, Li C, Maity A, Thomas-Tikhonenko A, Perl AE, Koong A, Fuchs SY, Diehl JA, Mills IG, Ruggero D, Koumenis C (2012)
    ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth
    J Clin Invest, 122 (12), 4621-34
    PubMed 23143306
  8. Lazarevic B, Hammarström C, Yang J, Ramberg H, Diep LM, Karlsen SJ, Kucuk O, Saatcioglu F, Taskèn KA, Svindland A (2012)
    The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy
    Br J Nutr, 108 (12), 2138-47
    PubMed 22397815
  9. Liu Y, Vlatkovic L, Sæter T, Servoll E, Waaler G, Nesland JM, Giercksky KE, Axcrona K (2012)
    Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune-evasive B7-H3-expressing cell population?
    Int J Urol, 19 (8), 749-56
    PubMed 22487487
  10. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z (2012)
    Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
    Tumour Biol, 33 (4), 967-78
    PubMed 22252524
  11. Malmström PU, Grabe M, Haug ES, Hellström P, Hermann GG, Mogensen K, Raitanen M, Wahlqvist R (2012)
    Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance
    Scand J Urol Nephrol, 46 (2), 108-16
    PubMed 22087730
  12. Mills IG (2012)
    Nuclear translocation and functions of growth factor receptors
    Semin Cell Dev Biol, 23 (2), 165-71
    PubMed 21930229
  13. Paulo P, Ribeiro FR, Santos J, Mesquita D, Almeida M, Barros-Silva JD, Itkonen H, Henrique R, Jerónimo C, Sveen A, Mills IG, Skotheim RI, Lothe RA, Teixeira MR (2012)
    Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements
    Neoplasia, 14 (7), 600-11
    PubMed 22904677
  14. Rosenblatt R, Sherif A, Rintala E, Wahlqvist R, Ullén A, Nilsson S, Malmström PU, Nordic Urothelial Cancer Group (2012)
    Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer
    Eur Urol, 61 (6), 1229-38
    PubMed 22189383
  15. Rud E, Baco E, Eggesbø HB (2012)
    MRI and ultrasound-guided prostate biopsy using soft image fusion
    Anticancer Res, 32 (8), 3383-9
    PubMed 22843919
  16. Schröder F, Crawford ED, Axcrona K, Payne H, Keane TE (2012)
    Androgen deprivation therapy: past, present and future
    BJU Int, 109 Suppl 6, 1-12
    PubMed 22672120
  17. Servoll E, Saeter T, Vlatkovic L, Lund T, Nesland J, Waaler G, Axcrona K, Beisland HO (2012)
    Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer
    BJU Int, 109 (10), 1489-94
    PubMed 21933333
  18. Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fosså SD (2012)
    Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother
    BJU Int, 109 (9), 1366-74
    PubMed 21999333
  19. Stensvold A, Dahl AA, Brennhovd B, Cvancarova M, Fosså SD, Lilleby W, Axcrona K, Smeland S (2012)
    Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
    Prostate, 72 (6), 668-76
    PubMed 21809351

Publications 2011

  1. Axcrona K, Vlatkovic L, Hovland J, Brennhovd B, Kongsgaard U, Giercksky KE (2011)
    Robot-assisted laparoscopic prostatectomy in a 68-year-old patient with previous heart transplantation and pelvic irradiation
    J Robot Surg, 6 (1), 81-83
    PubMed 22408687
  2. Berge V (2011)
    Editorial comment to transrectal high-intensity focused ultrasound for treatment of localized prostate cancer
    Int J Urol, 18 (5), 363-4
    PubMed 21453400
  3. Berge V, Baco E, Dahl AA, Karlsen SJ (2011)
    Health-related quality of life after salvage high-intensity focused ultrasound (HIFU) treatment for locally radiorecurrent prostate cancer
    Int J Urol, 18 (9), 646-51
    PubMed 21771102
  4. Dizeyi N, Hedlund P, Bjartell A, Tinzl M, Austild-Taskén K, Abrahamsson PA (2011)
    Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines
    Urol Oncol, 29 (4), 436-45
    PubMed 19926313
  5. Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Taskèn KA, Karlsen SJ (2011)
    Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial
    Nutr Cancer, 63 (6), 889-98
    PubMed 21714686
  6. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM, Suo Z (2011)
    Prostate cancer cell lines under hypoxia exhibit greater stem-like properties
    PLoS One, 6 (12), e29170
    PubMed 22216200
  7. Mitra AV, Bancroft EK, Barbachano Y, Page EC, Foster CS, Jameson C, Mitchell G, Lindeman GJ, Stapleton A, Suthers G, Evans DG, Cruger D, Blanco I, Mercer C, Kirk J, Maehle L, Hodgson S, Walker L, Izatt L, Douglas F, Tucker K, Dorkins H, Clowes V, Male A, Donaldson A et al. (2011)
    Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
    BJU Int, 107 (1), 28-39
    PubMed 20840664
  8. Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E (2011)
    Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group
    J Clin Oncol, 29 (15), 2032-9
    PubMed 21482994
  9. Ramberg H, Alshbib A, Berge V, Svindland A, Taskén KA (2011)
    Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
    Mol Cancer, 10, 50
    PubMed 21548940
  10. Stensvold A, Dahl AA, Fosså SD, Axcrona K, Lilleby W, Brennhovd B, Smeland S (2011)
    Clinicians' use of guidelines as illustrated by curative treatment of prostate cancer at a comprehensive cancer center
    Acta Oncol, 50 (3), 408-14
    PubMed 20586661
  11. Wedde TB, Lobmaier IV, Brennhovd B, Lohne F, Hall KS (2011)
    Primary Ewing's Sarcoma of the Kidney in a 73-Year-Old Man
    Sarcoma, 2011, 978319
    PubMed 21776194

Publications 2010

  1. Axcrona K, Brennhovd B, Andersen M, Berner A (2010)
    Sarcomatoid squamous cell carcinoma of the penis
    Acta Oncol, 49 (1), 128-30
    PubMed 20100148
  2. Berge V, Baco E, Karlsen SJ (2010)
    A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results
    Scand J Urol Nephrol, 44 (4), 223-7
    PubMed 20350272
  3. Hernes E, Kyrdalen A, Kvåle R, Hem E, Klepp O, Axcrona K, Fosså SD (2010)
    Initial management of prostate cancer: first year experience with the Norwegian National Prostate Cancer Registry
    BJU Int, 105 (6), 805-11; discussion 811
    PubMed 19735258
  4. Kvåle R, Møller B, Angelsen A, Dahl O, Fosså SD, Halvorsen OJ, Hoem L, Solberg A, Wahlqvist R, Bray F (2010)
    Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007
    Cancer Epidemiol, 34 (4), 359-67
    PubMed 20627840
  5. Orlin JR, Klevmark B, Bjørnsen L, Hermansen P, Sanchez M (2010)
    Two screening tests for urinary voiding dysfunction used in 209 consecutive patients undergoing lumbar spine operations
    Scand J Urol Nephrol, 44 (2), 106-12
    PubMed 20095869
  6. Røtterud R, Malmström PU, Wahlqvist R, Taskén KA (2010)
    The star chart to Ta bladder cancer: an unsophisticated analysis of two-dimensional gel electrophoresis proteome maps
    Scand J Urol Nephrol, 44 (2), 76-83
    PubMed 20059407
  7. Steinsvik EA, Fosså SD, Axcrona K, Fransson P, Widmark A, Dahl AA (2010)
    Do perceptions of adverse events differ between patients and physicians? Findings from a randomized, controlled trial of radical treatment for prostate cancer
    J Urol, 184 (2), 525-31
    PubMed 20620412

Publications 2009

  1. Bø K, Talseth T, Holme I (2009)
    Comment on Schiøtz et al.: Ten-year follow-up after conservative treatment of stress urinary incontinence
    Int Urogynecol J Pelvic Floor Dysfunct, 20 (2), 265
    PubMed 18941703
  2. Fosså SD, Egey A, Haukaas SA, Angelsen A, Klepp O, Berge V, Axcrona K, Lilleby W (2009)
    [Incorrect about hormone treatment in prostatic cancer]
    Tidsskr Nor Laegeforen, 129 (5), 429
    PubMed 19247406
  3. Kvåle R, Møller B, Wahlqvist R, Fosså SD, Berner A, Busch C, Kyrdalen AE, Svindland A, Viset T, Halvorsen OJ (2009)
    Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
    BJU Int, 103 (12), 1647-54
    PubMed 19154461
  4. Marangos IP, Kazaryan AM, Rosseland AR, Røsok BI, Carlsen HS, Kromann-Andersen B, Brennhovd B, Hauss HJ, Giercksky KE, Mathisen Ø, Edwin B (2009)
    Should we use laparoscopic adrenalectomy for metastases? Scandinavian multicenter study
    J Surg Oncol, 100 (1), 43-7
    PubMed 19431158
  5. Oldenburg J, Wahlqvist R, Fosså SD (2009)
    Late relapse of germ cell tumors
    World J Urol, 27 (4), 493-500
    PubMed 19373473

Publications 2008

  1. Lazarevic B, Karlsen SJ, Saatcioglu F (2008)
    Genistein differentially modulates androgen-responsive gene expression and activates JNK in LNCaP cells
    Oncol Rep, 19 (5), 1231-5
    PubMed 18425381
  2. Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA (2008)
    Hormonal regulation of beta2-adrenergic receptor level in prostate cancer
    Prostate, 68 (10), 1133-42
    PubMed 18454446
  3. Svendsen KO, Schultz A (2008)
    [Sexual dysfunction in men]
    Tidsskr Nor Laegeforen, 128 (4), 448-52
    PubMed 18274579

Publications 2007

  1. Axcrona K, Brennhovd B, Alfsen GC, Giercksky KE, Warloe T (2007)
    Photodynamic therapy with methyl aminolevulinate for atypial carcinoma in situ of the penis
    Scand J Urol Nephrol, 41 (6), 507-10
    PubMed 17853049
  2. Bakke A, Jensen KM, Jonsson O, Jónsson E, Månsson W, Paananen I, Schultz A, Thind P, Tuhkanen K (2007)
    The rationale behind recommendations for follow-up after urinary diversion: an evidence-based approach
    Scand J Urol Nephrol, 41 (4), 261-9
    PubMed 17763215
  3. Cunderlíková B, Wahlqvist R, Berner A, Vasovic V, Warloe T, Nesland JM, Peng Q (2007)
    Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples
    Cytopathology, 18 (2), 87-95
    PubMed 17397493
  4. Karlsen SJ, Renkel J, Tahir AR, Angelsen A, Diep LM (2007)
    Extracorporeal shockwave lithotripsy versus ureteroscopy for 5- to 10-mm stones in the proximal ureter: Prospective effectiveness patient-preference trial
    J Endourol, 21 (1), 28-33
    PubMed 17263604
  5. Kvissel AK, Ramberg H, Eide T, Svindland A, Skålhegg BS, Taskén KA (2007)
    Androgen dependent regulation of protein kinase A subunits in prostate cancer cells
    Cell Signal, 19 (2), 401-9
    PubMed 16949795
  6. Kvåle R, Auvinen A, Adami HO, Klint A, Hernes E, Møller B, Pukkala E, Storm HH, Tryggvadottir L, Tretli S, Wahlqvist R, Weiderpass E, Bray F (2007)
    Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries
    J Natl Cancer Inst, 99 (24), 1881-7
    PubMed 18073376
  7. Lilleby W, Axcrona K, Alfsen GC, Urnes T, Hole KH (2007)
    Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate
    Acta Oncol, 46 (8), 1195-7
    PubMed 17851841
  8. Røtterud R, Fosså SD, Nesland JM (2007)
    Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium
    Histol Histopathol, 22 (4), 349-63
    PubMed 17290345

Publications 2006

  1. Alexander Tønseth K, Egge T, Kolbenstvedt A, Hedlund H (2006)
    Evaluation of patients after treatment of arterial priapism with selective micro-embolization
    Scand J Urol Nephrol, 40 (1), 49-52
    PubMed 16452056
  2. Brennhovd B, Johnsrud K, Berner A, Bogsrud T, Waehre H, Giercksky KE, Axcrona K (2006)
    Sentinel node procedure in low-stage/low-grade penile carcinomas
    Scand J Urol Nephrol, 40 (3), 204-7
    PubMed 16809260
  3. Jensen D, Aasen S, Talseth T (2006)
    Uroflowmetry with simultaneous electromyography versus voiding video cystourethrography
    Scand J Urol Nephrol, 40 (3), 232-7
    PubMed 16809266
  4. Kvåle R, Skarre E, Tønne A, Kyrdalen AE, Norstein J, Angelsen A, Wahlqvist R, Fosså SD (2006)
    [Curative treatment of prostatic cancer in Norway in 1998 and 2001]
    Tidsskr Nor Laegeforen, 126 (7), 912-6
    PubMed 16554883
  5. Nilsen FS, Haug E, Heidemann M, Karlsen SJ (2006)
    Does rapid intraoperative parathyroid hormone analysis predict cure in patients undergoing surgery for primary hyperparathyroidism? A prospective study
    Scand J Surg, 95 (1), 28-32
    PubMed 16579252

Publications 2005

  1. Dizeyi N, Bjartell A, Hedlund P, Taskén KA, Gadaleanu V, Abrahamsson PA (2005)
    Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines
    Eur Urol, 47 (6), 895-900
    PubMed 15925089
  2. Fosså SD, Wahlqvist R (2005)
    [Radical treatment of prostatic cancer in Norway]
    Tidsskr Nor Laegeforen, 125 (20), 2834; author reply 2834-5
    PubMed 16244698
  3. Talseth T, Hedlund H (2005)
    [Frequent urination and fibromyalgia]
    Tidsskr Nor Laegeforen, 125 (5), 623-4; author reply 624
    PubMed 15776046
  4. Tønseth KA, Schultz A, Talseth T, Hedlund H (2005)
    [Treatment of erectile dysfunction with penile implants]
    Tidsskr Nor Laegeforen, 125 (13), 1825-7
    PubMed 16012552

Publications 2004

  1. Beisland C, Medby PC, Beisland HO (2004)
    Presumed radically treated renal cell carcinoma--recurrence of the disease and prognostic factors for subsequent survival
    Scand J Urol Nephrol, 38 (4), 299-305
    PubMed 15669589
  2. Klevmark B (2004)
    Detrusor contractility during emptying
    Scand J Urol Nephrol Suppl (215), 6-10
    PubMed 15545191
  3. Nordling J, Anjum FH, Bade JJ, Bouchelouche K, Bouchelouche P, Cervigni M, Elneil S, Fall M, Hald T, Hanus T, Hedlund H, Hohlbrugger G, Horn T, Larsen S, Leppilahti M, Mortensen S, Nagendra M, Oliveira PD, Osborne J, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ (2004)
    Primary evaluation of patients suspected of having interstitial cystitis (IC)
    Eur Urol, 45 (5), 662-9
    PubMed 15082211
  4. Padma-Nathan H, Christ G, Adaikan G, Becher E, Brock G, Carrier S, Carson C, Corbin J, Francis S, DeBusk R, Eardley I, Hedlund H, Hutter A, Jackson G, Kloner R, Lin CS, McVary K, McCullough A, Nehra A, Porst H, Schulman C, Seftel A, Sharlip I, Stief C, Teloken C (2004)
    Pharmacotherapy for erectile dysfunction
    J Sex Med, 1 (2), 128-40
    PubMed 16422967
  5. Seim A, Talseth T, Haukeland H, Høye K, Berg N, Bergeland T (2004)
    Validation of a simple patient questionnaire to assist self-detection of overactive bladder. A study in general practice
    Scand J Prim Health Care, 22 (4), 217-21
    PubMed 15765636

Publications 2003

  1. Jichlinski P, Guillou L, Karlsen SJ, Malmström PU, Jocham D, Brennhovd B, Johansson E, Gärtner T, Lange N, van den Bergh H, Leisinger HJ (2003)
    Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study
    J Urol, 170 (1), 226-9
    PubMed 12796694
  2. Karlsen SJ (2003)
    [Surgical treatment of urolithiasis]
    Tidsskr Nor Laegeforen, 123 (7), 938-40
    PubMed 12737067
  3. Kolbenstvedt A, Jenssen G, Hedlund H (2003)
    Priapism of the glans and corpus spongiosum. Report of two cases with angiography
    Acta Radiol, 44 (4), 456-9
    PubMed 12846700
  4. Schultz A, Hedlund H, Talseth T (2003)
    [Expandable penile implants in patients with erectile dysfunction]
    Tidsskr Nor Laegeforen, 123 (17), 2449-50
    PubMed 14562782

Publications 2002

  1. Beisland C, Medby PC, Beisland HO (2002)
    Renal cell carcinoma: gender difference in incidental detection and cancer-specific survival
    Scand J Urol Nephrol, 36 (6), 414-8
    PubMed 12623504
  2. Eri LM, Thomassen H, Brennhovd B, Håheim LL (2002)
    Accuracy and repeatability of prostate volume measurements by transrectal ultrasound
    Prostate Cancer Prostatic Dis, 5 (4), 273-8
    PubMed 12627211
  3. Eri LM, Wessel N, Tysland O, Berge V (2002)
    Comparative study of pressure-flow parameters
    Neurourol Urodyn, 21 (3), 186-93
    PubMed 11948710
  4. Frick IM, Axcrona K, Härdig Y, Tapper H, Gustafsson L, Kellner R, Leanderson T, Björck L (2002)
    Uptake and intracellular transportation of a bacterial surface protein in lymphoid cells
    Mol Microbiol, 44 (4), 917-34
    PubMed 12010489
  5. Hedlund H (2002)
    Clinical trial designs: is it possible to have a unified approach and common end points?
    Int J Impot Res, 14 Suppl 1, S35-7
    PubMed 11850733
  6. Hedlund H, Schultz A, Talseth T, Tonseth K, van der Hagen A (2002)
    Sacral neuromodulation in Norway: Clinical experience of the first three years
    Scand. J. Urol. Nephrol., 36 210, 87-94
  7. Hedlund H, Schultz A, Talseth T, Tonseth K, van der Hagen A (2002)
    Sacral neuromodulation in Norway: clinical experience of the first three years
    Scand J Urol Nephrol Suppl (210), 87-95
    PubMed 12475023
  8. Iversen P, Tammela TL, Vaage S, Lukkarinen O, Lodding P, Bull-Njaa T, Viitanen J, Hoisaeter P, Lundmo P, Rasmussen F, Johansson JE, Persson BE, Carroll K, Scandinavian Prostatic Cancer Group (SPCG) (2002)
    A randomised comparison of bicalutamide ('Casodex') 150 mg versus placebo as immediate therapy either alone or as adjuvant to standard care for early non-metastatic prostate cancer. First report from the Scandinavian Prostatic Cancer Group Study No. 6
    Eur Urol, 42 (3), 204-11
    PubMed 12234503

Publications 2001

  1. Argiolas A, Hedlund H (2001)
    The pharmacology and clinical pharmacokinetics of apomorphine SL
    BJU Int, 88 Suppl 3, 18-21
    PubMed 11578274
  2. Bø K, Lilleås F, Talseth T, Hedland H (2001)
    Dynamic MRI of the pelvic floor muscles in an upright sitting position
    Neurourol Urodyn, 20 (2), 167-74
    PubMed 11170191
  3. Dahle MK, Knutsen HK, Taskén KA, Pilz R, Taskén K (2001)
    Cyclic AMP regulates expression of the RI alpha subunit of cAMP-dependent protein kinase through an alternatively spliced 5' UTR
    Eur J Biochem, 268 (22), 5920-9
    PubMed 11722580
  4. Dahle MK, Reinton N, Orstavik S, Taskén KA, Taskén K (2001)
    Novel alternatively spliced mRNA (1c) of the protein kinase A RI? subunit is implicated in haploid germ cell specific expression
    Mol Reprod Dev, 59 (1), 11-6
    PubMed 11335941
  5. Eri LM, Svindland A, Tveter KJ (2001)
    The effect of bicalutamide on prostate histology
    Prostate, 46 (4), 275-80
    PubMed 11241549
  6. Eri LM, Tveter KJ (2001)
    Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)
    Prostate Cancer Prostatic Dis, 4 (3), 173-177
    PubMed 12497037
  7. Eri LM, Wessel N, Berge V (2001)
    Test-retest variation of pressure flow parameters in men with bladder outlet obstruction
    J Urol, 165 (4), 1188-92
    PubMed 11257668
  8. Fosså SD, Eri LM, Skovlund E, Tveter K, Vatten L, Norwegian Urological Cancer Group (2001)
    No randomised trial of prostate-cancer screening in Norway
    Lancet Oncol, 2 (12), 741-5; discussion 746-9
    PubMed 11902516
  9. Hedlund H, Bo K, Lilleas F, Talseth T, Tillung T (2001)
    The clinical value of dynamic magnetic resonance imaging in normal and incontinent women - A preliminary study on micturition
    Scand. J. Urol. Nephrol., 35 207, 87-91
  10. Hedlund H, Bø K, Lilleås F, Talseth T, Tillung T (2001)
    The clinical value of dynamic magnetic resonance imaging in normal and incontinent women--a preliminary study on micturition
    Scand J Urol Nephrol Suppl (207), 87-91; discussion 106-25
    PubMed 11409620
  11. Hedlund H, Hjelmås K, Jonsson O, Klarskov P, Talja M (2001)
    Hydrophilic versus non-coated catheters for intermittent catheterization
    Scand J Urol Nephrol, 35 (1), 49-53
    PubMed 11291688
  12. Jensen KM, Månsson W, Bakke A, Jonsson E, Jonsson O, Lindell O, Schultz A, Steven K, Tuhkanen K (2001)
    Reconstructive urology in the nordic countries--a hospital questionnaire survey
    Scand J Urol Nephrol, 35 (3), 186-9
    PubMed 11487069
  13. Karlsen SJ, Bull-Njaa T, Krokstad A (2001)
    Measurement of sound emission by endoscopic lithotripters: an in vitro study and theoretical estimation of risk of hearing loss in a fetus
    J Endourol, 15 (8), 821-6
    PubMed 11724122
  14. Lars LM, Sivertsen S, Nagelhus J (2001)
    The impact of participation in a study of medical treatment of lower urinary tract symptoms on the incidence of prostate surgery
    World J. Urol., 19 (4), 256-258
  15. Lindgren H, Axcrona K, Leanderson T (2001)
    Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2
    J Immunol, 166 (7), 4578-85
    PubMed 11254715
  16. Nilsen FS, Karlsen SJ, Gjertsen O (2001)
    Gas-containing renal stones treated with percutaneous nephrolithotomy: case report
    J Endourol, 15 (9), 915-7
    PubMed 11769846
  17. Scheepens WA, Weil EH, van Koeveringe GA, Rohrmann D, Hedlund HE, Schurch B, Ostardo E, Pastorello M, Ratto C, Nordling J, van Kerrebroeck PE (2001)
    Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation--a multicenter study
    Eur Urol, 40 (4), 434-8
    PubMed 11713399
  18. Taskén KA, Collas P, Kemmner WA, Witczak O, Conti M, Taskén K (2001)
    Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area
    J Biol Chem, 276 (25), 21999-2002
    PubMed 11285255
  19. Wessel N, Liestøl K, Maehlen J, Brorson SH (2001)
    The apolipoprotein E epsilon4 allele is no risk factor for prostate cancer in the Norwegian population
    Br J Cancer, 85 (9), 1418
    PubMed 11720484

Publications 2000

  1. Angelsen A, Talseth T, Mjønes JG, Hedlund H (2000)
    Hypertension and pseudoaneurism on the renal artery following retrograde endopyelotomy (Acucise)
    Scand J Urol Nephrol, 34 (1), 79-80
    PubMed 10757279
  2. Beisland C, Medby PC, Sander S, Beisland HO (2000)
    Nephrectomy - indications, complications and postoperative mortality in 646 consecutive patients
    Eur Urol, 37 (1), 58-64
    PubMed 10671787
  3. Bø K, Talseth T, Vinsnes A (2000)
    Randomized controlled trial on the effect of pelvic floor muscle training on quality of life and sexual problems in genuine stress incontinent women
    Acta Obstet Gynecol Scand, 79 (7), 598-603
    PubMed 10929962
  4. Eri LM, Svindland A (2000)
    Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
    Urology, 56 (2), 261-5
    PubMed 10925090
  5. Grønning LM, Wang JE, Ree AH, Haugen TB, Taskén K, Taskén KA (2000)
    Regulation of tissue inhibitor of metalloproteinases-1 in rat Sertoli cells: induction by germ cell residual bodies, interleukin-1alpha, and second messengers
    Biol Reprod, 62 (4), 1040-6
    PubMed 10727275
  6. Hedlund H (2000)
    [Sildenafil (Viagra)--a new drug in the treatment of erectile dysfunction]
    Tidsskr Nor Laegeforen, 120 (22), 2674-5
    PubMed 11077515
  7. Olson BJ, Skavdahl M, Ramberg H, Osterman JC, Markwell J (2000)
    Formate dehydrogenase in Arabidopsis thaliana: characterization and possible targeting to the chloroplast
    Plant Sci, 159 (2), 205-212
    PubMed 11074273